CRGX
insider transactionsCARGO Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-1.6K
0 buy · 1.6K sell
Net value · 365d
-$6.8K
$0 in · $6.8K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
1
0 buy · 1.6K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·D
Director
—
25.0K sh
Own -100%
-
Other·D
Director
—
25.0K sh
Own -100%
-
Other·D
Director
—
25.0K sh
Own -100%
-
Other·D
Director
—
25.0K sh
Own -100%
-
Other·D
See Remarks
—
14.7K sh
Own -100%
-
Other·D
See Remarks
$277.8K
63.4K sh · $4.38
Own -100%
-
Other·D
Director
—
15.9K sh
Own -100%
-
Other·D
Director
—
25.0K sh
Own -100%
-
Other·D
Director
—
3.2K sh
Own -100%
-
Other·D
Director
—
25.0K sh
Own -100%
-
Other·D
Director
—
25.0K sh
Own -100%
-
Other·U
See Remarks
$251.2K
57.3K sh · $4.38
-
Sell·S
See Remarks
$6.8K
1.6K sh · $4.18
Own -1%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2025 | Henderson Jane | Other D | 25.0K | — |
| Aug 19, 2025 | Bassan Abraham | Other D | 25.0K | — |
| Aug 19, 2025 | Huber Reid M | Other D | 25.0K | — |
| Aug 19, 2025 | Lubner David Charles | Other D | 25.0K | — |
| Aug 19, 2025 | Radhakrishnan Anup | Other D | 14.7K | — |
| Aug 19, 2025 | Radhakrishnan Anup | Other D | 63.4K | $277.8K |
| Aug 19, 2025 | Orwin John A | Other D | 15.9K | — |
| Aug 19, 2025 | Orwin John A | Other D | 25.0K | — |
| Aug 19, 2025 | Viswanadhan Krishnan | Other D | 3.2K | — |
| Aug 19, 2025 | Viswanadhan Krishnan | Other D | 25.0K | — |
| Aug 19, 2025 | Dhingra Kapil | Other D | 25.0K | — |
| Aug 18, 2025 | Radhakrishnan Anup | Other U | 57.3K | $251.2K |
| Jul 2, 2025 | Radhakrishnan Anup | Sell S | 1.6K | $6.8K |
About CRGX insider trading
This page tracks insider transactions for CARGO Therapeutics, Inc. (CRGX) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.